2m 2m 2m 2m 2m 2m 2m
ACURX PHARM (ACXP)
NASDAQ
$1.49+$0.02 (+1.16%)
Price as of Aug 21, 2026 7:50 PM EDT- $6.3MMarket Cap
- -68.82%1-Year Change
- BiotechnologyIndustry
ACURX PHARM (ACXP)
$1.49+$0.02 (+1.16%)
ACXP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.47 | ||
Change | +$0.02 (+1.38%) | ||
Open | $1.45 | ||
High | $1.53 | ||
Low | $1.45 | ||
Previous Close | $1.45 | ||
Volume | 84,594 | ||
30-Day Average Volume | 183,521 | ||
1-Week Change | 5.38% | ||
1-Month Change | -3.29% | ||
1-Year Change | -68.82% | ||
3-Year Change | -96.31% | ||
5-Year Change | -98.32% | ||
Fundamentals | |||
Shares Outstanding | 4.3M | ||
Total Assets | $11.0M | ||
Market Cap | $6.3M | ||
Enterprise Value | -$4.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$2.3M | ||
Free Cash Flow | -$1.7M | ||
EBIT | -$2.3M | ||
EBITDA | -$2.3M | ||
Net Working Capital | $8.1M | ||
EPS | -$0.53 | ||
Enterprise Value/EBITDA | 2 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -3 | ||
PEG | -0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 08/05/2025 | ||
Earnings & Revenue